JPMorgan Funds - Thematics - Genetic Therapies C2 (inc) - EUR Hedged (0P0001INX2)
Market Closed
14 Aug, 20:00
XFRA XFRA Primary €
122. 79
+0.86
+0.7053%
€
- Market Cap
2.22% Div Yield
0 Volume
€ 121.93
Previous Close Want to track 0P0001INX2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
0P0001INX2 closed Friday higher at €122.79, an increase of 0.7053% from Thursday's close, completing a monthly increase of 0% or €122.79. Over the past 12 months, 0P0001INX2 stock gained 16.5875%.
0P0001INX2 pays dividends to its shareholders, with the most recent payment made on Sep 24, 2025.
The stock of the company had never split.
The company's stock is traded on one exchange.
0P0001INX2 Chart
JPMorgan Funds - Thematics - Genetic Therapies C2 (inc) - EUR Hedged (0P0001INX2) FAQ
What is the stock price today?
The current price is €122.79.
On which exchange is it traded?
JPMorgan Funds - Thematics - Genetic Therapies C2 (inc) - EUR Hedged is listed on XFRA.
What is its stock symbol?
The ticker symbol is 0P0001INX2.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.22%.
What is its market cap?
As of today, no market cap data is available.
Has JPMorgan Funds - Thematics - Genetic Therapies C2 (inc) - EUR Hedged ever had a stock split?
No, there has never been a stock split.
JPMorgan Funds - Thematics - Genetic Therapies C2 (inc) - EUR Hedged Profile
| XFRA Exchange | US Country |
Contact Information
Address: -
Phone: -
